Tuesday, October 28, 2025
- 3:30PM-3:45PM
-
Abstract Number: 2605
Do Patients Recall Their Rheumatic Diagnoses Accurately? A Comparison by Disease Type
Abstracts: ARP II: Perception, Prediction, and Prevention (2603–2608)- 3:30PM-3:45PM
-
Abstract Number: 2611
Exploring the Role of a Lung Ultrasound Score in the Assessment of Severity of Connective Tissue Disease-Related Interstitial Lung Disease
Abstracts: Imaging of Rheumatic Diseases (2609–2614)- 3:30PM-3:45PM
-
Abstract Number: 2629
Predictors of 30-day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Impact of Social Determinants of Health.
Abstracts: Reproductive Issues in Rheumatic Disorders (2627–2632)- 3:45PM-4:00PM
-
Abstract Number: 2636
Autoantibodies to 14-3-3 eta: A Novel Diagnostic Biomarker for Axial Spondyloarthritis
Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes II: Advances in Axial Spondyloarthritis (2633–2638)- 3:45PM-4:00PM
-
Abstract Number: 2612
Automated, Artificial Intelligence-supported Sonographic Examination of the Hands for the Detection and Quantification of Arthritis and Osteoarthritis in the Hand and Finger Joints in Outpatient Rheumatology Care
Abstracts: Imaging of Rheumatic Diseases (2609–2614)- 3:45PM-4:00PM
-
Abstract Number: 2618
Effect of Implementing a Dashboard with or without a Best Practice Alert on HLA-B*58:01 Testing Rates among Allopurinol Users at VA Medical Centers
Abstracts: Measures & Measurement of Healthcare Quality (2615–2620)- 3:45PM-4:00PM
-
Abstract Number: 2624
Results of Large Multi-Site Pragmatic Clinical Trial Comparing Corticosteroids or Blinded Lidocaine-only Injections in Treating Osteoarthritis of the Knee
Abstracts: Osteoarthritis – Clinical (2621–2626)- 3:45PM-4:00PM
-
Abstract Number: 2630
The Absence of DORIS Remission Is Associated with Greater Risk of Preterm Birth and Preeclampsia in SLE Pregnancies
Abstracts: Reproductive Issues in Rheumatic Disorders (2627–2632)- 3:45PM-4:00PM
-
Abstract Number: 2606
The Impact of Social Media and Artificial Intelligence on Illness Perception and Treatment Adherence in Patients with Rheumatic Diseases
Abstracts: ARP II: Perception, Prediction, and Prevention (2603–2608)- 4:00PM-4:15PM
-
Abstract Number: 2631
Dapirolizumab Pegol, a Novel CD40L Inhibitor, Showed No Adverse Outcomes in an In Vivo Non-Human Primate Reprotoxicity Study and Displayed Minimal to No Human Placental Transfer in an Ex Vivo Study
Abstracts: Reproductive Issues in Rheumatic Disorders (2627–2632)- 4:00PM-4:15PM
-
Abstract Number: 2625
Early Detection of Knee Osteoarthritis – The Role of a Composite Disease Activity Metric: Data from the Osteoarthritis Initiative
Abstracts: Osteoarthritis – Clinical (2621–2626)- 4:00PM-4:15PM
-
Abstract Number: 2607
ERS-RA as a Tool for Cardiovascular Risk Prediction in Established Rheumatoid Arthritis: An External Validation
Abstracts: ARP II: Perception, Prediction, and Prevention (2603–2608)- 4:00PM-4:15PM
-
Abstract Number: 2613
Ga-FAPI-04 PET/CT reveals increased fibroblast activation in synovial and enthesial tissues of psoriasis patients with arthralgia and predicts the development of psoriatic arthritis
Abstracts: Imaging of Rheumatic Diseases (2609–2614)- 4:00PM-4:15PM
-
Abstract Number: 2637
Initial Phospholipid Transferase Activity Is Predictive of Five-Year Sacroiliac Radiographic Progression in Axial Spondyloarthritis: Findings From the DESIR Cohort
Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes II: Advances in Axial Spondyloarthritis (2633–2638)- 4:00PM-4:15PM
-
Abstract Number: 2619
What Works? A Consolidated Framework for Implementation Research-Guided Exploration of Patient Safety in Rheumatology Practices